MXD4: A Key Regulator of Immune System Function (G10608)

Target Name: MXD4

NCBI ID: G10608

MXD4

MXD4: A Key Regulator of Immune System Function

MXD4, or Max Dimerizer 4, is a protein that is expressed in various tissues throughout the body. It is a key player in the immune system, playing a crucial role in the regulation of cell division and the response to stress. MXD4 has also been shown to have potential as a drug target and biomarker for various diseases, including cancer.

MXD4 was first identified in the late 1990s as a key regulator of cell division in the T cells, which are a crucial part of the immune system. Researchers found that MXD4 was highly expressed in T cells and that it was involved in the regulation of cell growth, apoptosis, and survival. MXD4 has since been shown to play a role in the development and progression of various diseases, including cancer.

One of the key functions of MXD4 is its role in cell division. MXD4 is involved in the regulation of the cell cycle, including the G1/S transition, which is the stage at which a cell prepares for cell division. MXD4 has been shown to play a key role in regulating the G1/S transition and in the regulation of cell cycle progression. This is important because a cell that is able to properly divide and grow is essential for the overall health and survival of the organism.

Another function of MXD4 is its role in stress response. MXD4 is involved in the regulation of cellular stress responses, including the response to oxidative stress and inflammation. This is important because stress can have a negative impact on the immune system and contribute to the development and progression of various diseases. MXD4 has been shown to play a key role in regulating the response to stress and in the regulation of cellular stress responses.

In addition to its role in cell division and stress response, MXD4 has also been shown to play a role in the regulation of inflammation. MXD4 is involved in the regulation of the immune response and in the regulation of inflammation. This is important because inflammation can contribute to the development and progression of various diseases, including cancer. MXD4 has been shown to play a key role in regulating the immune response and in the regulation of inflammation.

As a drug target, MXD4 has the potential to be used for the treatment of various diseases, including cancer. For example, MXD4 has been shown to be involved in the regulation of the immune response and in the regulation of cell division, which makes it a potential target for cancer treatments that target these processes. In addition, MXD4 has also been shown to play a role in the regulation of stress responses and in the regulation of inflammation, which may also make it a potential target for diseases that are characterized by these processes.

In conclusion, MXD4 is a protein that is involved in various functions in the immune system, including cell division, stress response, and inflammation. As a drug target and biomarker, MXD4 has the potential to be used for the treatment of various diseases, including cancer. Further research is needed to fully understand the role of MXD4 in the immune system and its potential as a drug target and biomarker.

Protein Name: MAX Dimerization Protein 4

Functions: Transcriptional repressor. Binds with MAX to form a sequence-specific DNA-binding protein complex which recognizes the core sequence 5'-CAC[GA]TG-3'. Antagonizes MYC transcriptional activity by competing for MAX and suppresses MYC dependent cell transformation (By similarity)

The "MXD4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MXD4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets